|
- Roche - Doing now what patients need next
As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally
- Roche - Wikipedia
Roche operates under a divisional organizational structure led by a Chief Executive Officer who oversees the company's two main business divisions: Roche Pharmaceuticals and Roche Diagnostics
- Our history - Roche
Roche was founded in Switzerland in 1896 as one of the first companies specifically set up to manufacture scientifically researched pharmaceuticals Already at an early stage the company expanded to other countries such as Italy and Germany
- Roche is Back in Alzheimer’s as Latest Antibody Clears . . . - BioSpace
More than nine in 10 patients treated with Roche’s next-generation Alzheimer’s disease antibody trontinemab tested negative for amyloid plaques in a mid-stage study, marking a return to the neurodegenerative disease for the Swiss pharma after years away to recalibrate In the ongoing Phase I II
- Assessing Roche After Pipeline Wins and a 24% Rally in 2025
Ever wondered if Roche Holding is trading at a bargain or a premium? You are not alone, especially with all the chatter about big pharma valuations these days The stock has shown some real
- Roche Diagnostics
Learn more about our portfolio of lab instruments, systems, assays and more More than 800,000 documents available on demand — always up-to-date with 24 7 access Empowering learning — e-learning content, PACE CEU courses, and more
- Roche links SERD to 30% breast cancer risk reduction in phase 3
Roche has lifted the lid on the data behind its second phase 3 giredestrant win, linking the oral selective estrogen receptor degrader (SERD) to a 30% reduction in the risk of invasive disease
- Roche’s Potential Blockbuster Fuels Best Month Since 1997
Roche Holding AG’s shares just posted their best month since 1997, lifted by optimism over an experimental breast cancer pill and encouraging trial results Analysts see further gains ahead
|
|
|